Filing Details
- Accession Number:
- 0001854270-25-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-06 19:53:06
- Reporting Period:
- 2025-02-04
- Filing Date:
- 2025-02-06
- Accepted Time:
- 2025-02-06 19:53:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1854270 | Senti Biosciences Inc. | SNTI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1816676 | Kanya Rajangam | C/O Senti Biosciences, Inc. 2 Corporate Drive First Floor South San Francisco CA 94080 | Pres. & Chief Med. & Dev. Off. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-02-04 | 1,297 | $4.07 | 8,803 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-02-06 | 182 | $4.37 | 8,621 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.